Cancer medicines

Ixazomib

Ixazomib

An oral proteasome inhibitor for myeloma.

Sources checked · Introductory guide

On this page

How it works

It blocks proteasome protein processing to promote cancer cell death.[3]

Where it is used

Combined with lenalidomide and dexamethasone in selected previously treated multiple myeloma.[1]

Key safety points

Monitor low platelets, neuropathy and digestive symptoms. Confirm dosing days and food instructions; report bleeding, severe numbness or jaundice immediately.[2]

Questions for your care team

  • How do I distinguish the three medicines’ dosing, breaks and test schedules?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Ixazomib Citrate (opens in a new tab)
  2. MedlinePlus · Ixazomib Citrate (opens in a new tab)
  3. NCI Drug Dictionary · Ixazomib Citrate (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Ixazomib | Cancer Encyclopedia | My Chemo Diary